| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.45B | 9.64B | 7.07B | 4.88B | 2.68B | 1.33B |
| Gross Profit | 1.34B | 1.29B | 995.24M | 678.77M | 624.11M | 492.22M |
| EBITDA | 2.46B | 2.62B | 2.19B | 1.07B | 348.23M | 257.76M |
| Net Income | 1.48B | 1.44B | 1.19B | 397.76M | 145.51M | 287.27M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 91.68B | 62.80B | 43.06B | 28.54B | 17.51B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 5.53B | 883.64M | 2.12B | 1.60B | 3.53B |
| Total Debt | 0.00 | 69.04B | 46.53B | 31.49B | 18.31B | 7.88B |
| Total Liabilities | -20.46B | 71.22B | 48.42B | 33.22B | 18.88B | 7.98B |
| Stockholders Equity | 20.46B | 20.46B | 14.38B | 9.84B | 9.67B | 9.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -25.00B | -15.38B | -12.61B | -11.46B | -3.59B |
| Operating Cash Flow | 0.00 | -24.74B | -15.35B | -12.20B | -11.32B | -3.47B |
| Investing Cash Flow | 0.00 | -799.24M | -2.30B | -845.42M | 413.80M | -459.17M |
| Financing Cash Flow | 0.00 | 26.55B | 18.14B | 12.79B | 10.23B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹15.68B | -1,420.68 | ― | ― | -6.03% | -100.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | ₹32.40B | 29.73 | ― | 0.90% | 5.73% | 12.29% | |
53 Neutral | ₹20.56B | 11.39 | ― | ― | 33.99% | 11.65% | |
51 Neutral | ₹32.97B | ― | ― | ― | -10.17% | -181.71% | |
48 Neutral | ₹21.54B | -1.23 | ― | ― | -45.13% | -1646.01% |
Ugro Capital Limited has announced the conversion of its compulsorily convertible debentures (CCDs) into equity shares, following the expiration of the 18-month tenure of the CCDs issued in June 2024. This conversion has resulted in the issuance of 7,342,732 new equity shares, increasing the company’s total equity share capital. The conversion aligns with the company’s strategic capital raise plan, while the unexercised warrants from the same issuance have lapsed, impacting the company’s financial structuring and market positioning.
UGRO Capital Limited has announced the conversion of its Compulsorily Convertible Debentures (CCDs) into equity shares, following the expiration of their 18-month tenure. This conversion increases the company’s equity share capital, reflecting a strategic move to strengthen its financial structure and market position. The conversion of 7,342,732 equity shares will align with existing shares, while unexercised warrants will lapse, impacting the company’s capital dynamics.
UGRO Capital Limited has released a Monitoring Agency Report for the quarter ended September 30, 2025, detailing the utilization of proceeds from its preferential and rights issues. The report, prepared by India Ratings & Research Private Limited, complies with SEBI regulations and highlights the company’s adherence to capital utilization guidelines, potentially impacting its financial transparency and stakeholder confidence.
UGRO Capital Limited has announced the allotment of equity shares following the conversion of Compulsorily Convertible Debentures (CCDs), raising INR 534.64 crores. This conversion increases the company’s equity share capital, indicating a strategic move to strengthen its financial position and enhance shareholder value.
Ugro Capital Limited announced the allotment of listed Commercial Papers, approved by its Investment and Borrowing Committee. This move, involving securities with a face value of Rs. 5,00,000 each, is part of the company’s strategy to enhance its financial offerings and strengthen its market position. The commercial papers are set to be redeemed on 17th March 2026, with an issue value of Rs. 14,45,25,900 and a redemption value of Rs. 15,00,00,000, indicating a strategic financial maneuver to optimize returns and liquidity.
Ugro Capital Limited has announced the issuance of up to 300,000 non-convertible debentures (NCDs) on a private placement basis, with a face value of INR 10,000 each, totaling INR 300 crore. This strategic move, approved by the company’s Investment and Borrowing Committee, includes a green shoe option to retain oversubscription of up to 150,000 additional NCDs, potentially raising an additional INR 150 crore. The issuance is part of Ugro Capital’s efforts to strengthen its financial position and expand its credit offerings, impacting its market presence and providing opportunities for investors.
Ugro Capital Limited has announced the closure of its trading window in compliance with SEBI’s Prohibition of Insider Trading Regulations, 2015. This closure will be in effect from September 29, 2025, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ending September 30, 2025. This measure is part of the company’s Code of Conduct for Prohibition of Insider Trading, impacting directors, specified persons, and their immediate relatives, ensuring compliance and transparency in financial reporting.
UGRO Capital Limited has received approval from the Reserve Bank of India for its proposed acquisition of Profectus Capital Private Limited, with the transaction expected to close by October 31, 2025. Additionally, the company has adjusted the terms of its Compulsorily Convertible Debentures to facilitate the acquisition, ensuring the coupon is paid immediately post-allotment.